News & Analysis on Clinical Trial Services & Contract Research And Development
A novel approach to treating tuberculosis (TB), focusing on a potential drug target in the cell walls of Mycobacterium tuberculosis, the bacterium that causes TB, a disease that is reappearing as new, multiresistant drug-strains.
Contract service provider, GeneLogic, has formed a partnership with Millenium Pharmaceuticals acquiring a technology program and an associated research team as part of the deal. Millenium becomes the first customer for this new service as GeneLogic...
UK chemicals group Croda said strong demand for its marine and plant-derived oils in the personal care and healthcare sectors lifted sales and helped improve first half operating profits.
Scientists who have discovered the binding site for the anti-epilepsy drug Keppra have confirmed that the drugs mechanism of action places it in a new class of central nervous system (CNS) drugs.
The reality of the violence of some UK animal activists became apparent after GlaxoSmithKline (GSK), Europes's biggest drug maker, warned that investment and jobs would be driven out of the country by their actions.
Celera Diagnostics announced it has entered into a collaboration with Merck to identify novel targets for drug discovery and diagnostic markers related to Alzheimer's disease.
The Irish government is joining Johnson & Johnson subsidiary Centocor in a €650 million investment in a new manufacturing facility, it said this week. The move comes as some have questioned the country's capacity to remain a leading destination for...